Osteoporosis International (ISSN 0937-941X) is a prestigious monthly journal published by Springer Nature in the United Kingdom, serving as a leading venue for high-quality research on osteoporosis and related metabolic bone diseases. As an SCI-indexed publication that typically ranks within the top tiers of the Chinese Academy of Sciences journal categories in medicine, endocrinology, and metabolism, the journal is renowned for its rigorous peer-review process and significant impact factor. Its scope encompasses a broad spectrum of clinical and basic investigations, including epidemiology, pathophysiological mechanisms, diagnostic and therapeutic strategies, drug development, and public health implications, with a particular emphasis on multidisciplinary approaches to bone health. While the journal operates on a hybrid model offering partial open access options, it remains a highly selective platform that may involve longer review cycles and substantial article processing charges, making it an authoritative destination for researchers seeking to disseminate impactful and compliant academic findings in the field of bone biology and clinical osteology.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com